Brief Communications |
Headline : None
Date : Friday, 02 May 2025
Start Time : 08:30
End Time : 10:30
Location : Hall 2
|
Presentations |
|
08:40 - 08:50
|
Evaluating The Effect Of L-carnitine Supplement On Fatigue Severity In Patients With Multiple Sclerosis
Daryoush Savadi Oskuei |
08:50 - 09:00
|
Intravenous Thrombolysis In Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset
Abdoreza Ghoreishi |
09:00 - 09:10
|
Neurological Immune-Related Adverse Events In Patients Treated With Anti-PD-1 Agent, Pembrolizumab: A Case Series
Sepehr Khosravi |
09:10 - 09:20
|
Preventive Medications In Pediatric Migraine A Network Meta-Analysis
Omid Kohandel Gargari |
09:20 - 09:30
|
Cognitive Rehabilitation In Multiple Sclerosis And Systemic Lupus Erythematosus: A Pathway To Improved Cognitive Function And Quality Of Life
Mehrdad Roozbeh |
09:30 - 09:40
|
Comprehensive Review Of The Cardiovascular Complications Of The FDA-approved Anti-MS Modifying Therapies
Mehdi Maghbooli |
|
09:50 - 10:00
|
Is It Time To Prolong Dual Antiplatelet Therapy Using De-escalation Strategy In Minor Ischemic Stroke? Evidence From One-year Follow-up Analysis Of TACAMINIS Study
Athena Sharifi Razavi |
10:00 - 10:10
|
Evaluation Of The Efficacy Of Fingolimod And Alteplase Combination In Treatment Of Acute Ischemic Stroke
Hamed Shahriyari |
10:10 - 10:20
|
Ghost Tumor In Central Nervous System; A Case Report And Narrative Review
Mohammad Amin Najafi |
10:20 - 10:30
|
A Hybrid Machine Learning And Deep Learning Approach For Intracerebral Hemorrhage Detection On CT-Scan Images
Sogand Abbasi Azizi |